Bridging Classical Ayurveda and Modern Medicine in the Understanding of Shvitra (Vitiligo)

Abstract

Vitiligo is a chronic dermatological disorder characterized by the loss of melanocytes, leading to depigmented skin patches. Ayurveda describes it as Shvitra or Kilasa and attributes its etiology to Doṣha imbalances and impaired digestive function (Agnimandya), while contemporary medicine identifies autoimmunity, genetic susceptibility, and oxidative stress as the key etiological factors. This comparative analytical review was done by referring to classical Ayurvedic texts such as Charaka Saṃhita, Sushruta Saṃhita, Aṣṭanga Hṛidaya, and Kashyapa Saṃhita apart from the contemporary dermatology literature regarding etiology, classification, diagnostic tools, and therapeutic approaches, elucidating the integrative strategies. Ayurveda interprets Shvitra as a result of improper diet, impaired Agni, and Doṣha vitiation, whereas in modern science, autoimmune mechanisms, especially CD8+ T-cell–mediated melanocyte destruction, with genetic predisposition as a major risk factor, are identified. Therapeutic approaches in Ayurveda consist of Shodhana (purificatory measures), Shamana (palliative therapies), and Rasayana (rejuvenative therapies), whereas modern management involves topical and systemic corticosteroids, calcineurin inhibitors, phototherapy, and surgical grafting. Integrating the two may provide for a holistic, patient-centered care wherein Ayurvedic Rasayana therapies support the modern immunomodulatory and phototherapeutic interventions, reducing recurrence and improving the long-term outcome. The bridging of the two approaches presents an opportunity to enhance therapeutic efficacy, minimize the relapse, and improve the overall quality of life in patients affected by vitiligo.